Biotechnology News

May 3, 2012

NEW YORK--(BUSINESS WIRE)--Manhattan Research Releases New iPad Rep Report to Help Pharma Optimize Investments in 2012

May 3, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases, announced today the...

May 3, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus Inc. (NASDAQ: ZLCS) today reported financial results for the first quarter ended March 31, 2012. “We made tremendous progress advancing our pipeline this quarter and will continue this momentum with...

May 3, 2012

WASHINGTON--(BUSINESS WIRE)--cooperative agreement intended to help federal and private-sector employees improve efficiencies and reduce costs by expanding use of existing cyber-identities signed by leading identity trust hubs

May 3, 2012

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead to Present at Upcoming Scientific Conferences; Results Demonstrating Effectiveness of DPC siRNA Delivery System and Path to the Clinic for siRNA-based Hepatitis B Treatment

May 3, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen reported first quarter of 2012 earnings and strong bioprocessing business growth following December 2011 strategic acquisition.

May 3, 2012

BOULDER, Colo. & MILWAUKEE--(BUSINESS WIRE)--Covidien (NYSE: COV) and GE Healthcare (NYSE: GE), leading global providers of healthcare products and recognized innovators in patient monitoring and respiratory care devices, today announced a...

May 3, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today announced that data from several company-sponsored studies of naltrexone for extended-release injectable suspension (XR-NTX) are scheduled to be presented at the 2012 American Psychiatric...

May 3, 2012

WOBURN, Mass.--(BUSINESS WIRE)--ArQule reports first quarter fiscal year 2012 results.

May 3, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta (NASDAQ: SNTA) today provided a clinical program update and reported financial results for the quarter ended March 31, 2012. Company announces plans to proceed into Phase 3 by year-end.

May 3, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today announced top-line results of a randomized, controlled Phase 2 clinical trial of IMO-2055, the Company’s investigational oncology product candidate targeting Toll...

May 3, 2012

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced its financial results for the first quarter ended March 31, 2012. “AMPYRA continues to make unique and important contributions to the lives of people with...

May 3, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced a broad expansion of the cabozantinib development program under a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute...

May 3, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--Global Scientific Community Embraces New Parkinson’s Therapy

May 3, 2012

PARIS--(BUSINESS WIRE)--Biomedical Diagnostics (BMD) becomes Theradiag and moves into theranostics

May 3, 2012

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine (STO:AEROB): January – March 2012 Global Net sales grew by 76% to SEK 39.0m (22.2). Adjusted for currency fluctuations, net sales rose by 72% The worldwide number of NIOX MINO® repeat...

May 3, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Paris:IPN) (Euronext: IPN; ADR: IPSEY) reported today its sales for the first quarter 2012. First quarter 2012 unaudited IFRS consolidated sales   (in million euros)       2012       2011       %...

May 3, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the SUMMACTA study met its primary endpoint, showing comparable efficacy (non-inferiority) of the subcutaneous...

May 3, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme announced today that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved a second suite for filling and finishing product at its Waterford, Ireland m

May 3, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that its Board of Directors declared a second quarter dividend of $0.23 per common share. This dividend amount is equal to the...

May 2, 2012

MINNEAPOLIS & MELBOURNE, Australia--(BUSINESS WIRE)--Osprey Medical today announced that it has successfully listed on the ASX, under the ticker “OSP”. The stock has listed at a premium, gaining 5% in early trading on the ASX this morning. “...

May 2, 2012

MILWAUKEE--(BUSINESS WIRE)--Cynthia Dohmen LaConte named semin-finalist in E & Y's Entrepreneur of the Year Upper Midwest.

May 2, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE Amex: NAVB) Announces First Quarter 2012 Results: Business Update / Quarterly Conference Call Set for Tomorrow, May 3, 2012, at 8:30 am EDT

May 2, 2012

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec to Present at Deutsche Bank Conference

May 2, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) announced today that Frank Karbe, the company’s executive vice president and chief financial officer, will present at the upcoming Deutsche Bank Securities 37th Annual...

May 2, 2012

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB: FCSC), an autologous cellular therapeutic company focused on the development of innovative products for aesthetic, medical and scientific applications, announced today that David...

May 2, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River announces first-quarter 2012 results

May 2, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo will host a webcast and conference call to discuss first quarter 2012 highlights and results on May 9, 2012, at 5 pm Eastern.

May 2, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Vertex will webcast its presentation at the Deutsche Bank 37th Annual Health Care Conference on Tuesday, May 8, 2012 at 11:20 a.m. EDT and...

May 2, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) announced today that it will present at the Bank of America Merrill Lynch 2012 Healthcare Conference on Wednesday, May 16, 2012, at 11:20 a.m. PT. The live webcast of Baxter’...

May 2, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the first quarter ended March 31, 2012, and provided an operating forecast and program updates. "2012 has opened strong for Ligand...

May 2, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today its financial results for the first quarter ended March 31, 2012. Revenues for the quarter were $10.4 million, compared to $0.4 million for the same period in...

May 2, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company will present at the Bank of America Merrill Lynch 2012...

May 2, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB: ILIU) announced today that it will host a conference call and Webcast on Thursday, May 10, 2012 at 4:30 p.m. ET to discuss the Company’s first quarter results. To access the live...

May 2, 2012

WEST CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Azelon Pharmaceuticals, Inc., a biopharmaceutical company developing treatments for osteoporosis, announces the completion of a phase 2a trial comparing nasal spray ZT-034 to Forteo administered by...

May 2, 2012

SAN ANTONIO--(BUSINESS WIRE)--The KCI Graftjacket(R) Regenerative Tissue Matrix Reimbursed by Medicare in Eight Midwestern States; Approximately 7.5 Million People Gain Access to Proven Safe, Effective Treatment Option for DFUs

May 2, 2012

SAN JOSE, Calif.--(BUSINESS WIRE)--Press and analysts attending CLEO: 2012 are invited to the press luncheon titled "Biophotonics for Cancer Detection, Diagnosis, and Treatment", May 9 at noon in the San Jose Convention Center.

May 2, 2012

PITTSBURGH--(BUSINESS WIRE)--Knopp Biosciences LLC today announced the recruiting of key scientific executives and the completion of a significant laboratory build-out as part of its expanded activity in pharmaceutical discovery. In addition to...

May 2, 2012

BALTIMORE--(BUSINESS WIRE)--Profectus BioSciences receives NIAID grant to develop a vesicular stomatitis virus-vectored vaccine for Ebola and Marburg viruses.

May 2, 2012

CARY, N.C.--(BUSINESS WIRE)--Pharma decision-makers weigh in on topics effecting patient recruitment, including: drivers and barriers to success, valuable recruitment channels and methodologies, and the use of service providers.

May 2, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Xcellerex, Inc. has launched its XDUO™ Quad™ single-use mixing system supporting single-use biomanufacturing in upstream and downstream mixing applications and unit operations.

May 2, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Cutting Edge Information’s study, “Market Access Management: Building Teams that Deliver Value to Payers,” says a quarter of pharmaceutical companies now fund and staff a separate Market Access group...

May 2, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic (OSE:DIAG) JAD award 2012 (http://mb.cision.com/...

May 2, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--TearScience's LipiFlow treatment is emerging as the new standard of care for evaporative dry eye and will be available in 40 premier ophthalmic practices in North America by July, 2012.

May 2, 2012

PARIS & PHILADELPHIA--(BUSINESS WIRE)--Nanobiotix and Thomas Jefferson University Start Research Collaboration.

May 2, 2012

MORGAN HILL, Calif.--(BUSINESS WIRE)--Aragen Bioscience Inc. and XOMA Corporation announce a partnership to offer XOMA’s antibody humanization technology, Human Engineering™, through Aragen Bioscience’s contract services.

May 2, 2012

HERCULES, Calif.--(BUSINESS WIRE)--Using Next Generation Sequencing, Eureka has developed low cost, low density marker assays to address the gap between traditional array technologies and multiplex PCR for clinical and AgBio markets

May 2, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Design and technology consultancy Cambridge Design Partnership today announces that it has completed a research project to identify the future of medical technology to treat Atrial Fibrillation